Marijuana as Treatment Lacks Sufficient Scientific Study, but Preserve Patient-Physician Dialogue - 07/06/2017
In 2015, TMA completed a systemic review of the research and clinical indications of marijuana, its compounds, and its potential risks and therapeutic benefits. Having reviewed more than two decades of studies, we confidently join other medical associations in recognizing there is a lack of science and practice on the medical effects of marijuana to inform physicians adequately about its proper application and use for various health conditions. Unfortunately, the lack of expanded study and evidence on marijuana as medicine is because of its Schedule 1 classification, which has greatly limited the types and rigor of research. We have endorsed a rescheduling of marijuana to facilitate research — including cannabinoid-based medications, as well as the most appropriate delivery methods.